Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-29

Clinical Trial Update: Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain [Phase 2]

View source ↗

Summary

Phase 2 trial comparing buprenorphine sublingual spray to standard narcotic therapy for postoperative pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buprenorphine Sublingual Spray (buprenorphine)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Pain, Postoperative | Phase 2 | Status: COMPLETED | Results posted: 2018-10-29